Now Accepting Letters of Intent for 2027 Research Grants! Explore Funding Opportunities
SCA38 Treatment Pipeline Tracking progress of the development of SCA38 therapies. Pipeline for SCA38 This is a visual tool created to show the progress of SCA38 therapies that are currently Read More…
SCA17 Treatment Pipeline Tracking progress of the development of SCA17 therapies. Pipeline for SCA17 This is a visual tool created to show the progress of SCA17 therapies that are currently Read More…
SCA10 Treatment Pipeline Tracking progress of the development of SCA10 therapies. Pipeline for SCA10 This is a visual tool created to show the progress of SCA10 therapies that are currently Read More…
SCA8 Treatment Pipeline Tracking progress of the development of SCA8 therapies. Pipeline for SCA8 This is a visual tool created to show the progress of SCA8 therapies that are currently Read More…
SCA7 Treatment Pipeline Tracking progress of the development of SCA7 therapies. Pipeline for SCA7 This is a visual tool created to show the progress of SCA7 therapies that are currently Read More…
SCA6 Treatment Pipeline Tracking progress of the development of SCA6 therapies. Pipeline for SCA6 This is a visual tool created to show the progress of SCA6 therapies that are currently Read More…
SCA3 Treatment Pipeline Tracking progress of the development of SCA3 therapies. Pipeline for SCA3 This is a visual tool created to show the progress of SCA3 therapies that are currently Read More…
SCA1 Treatment Pipeline Tracking progress of the development of SCA1 therapies. Pipeline for SCA1 This is a visual tool created to show the progress of SCA1 therapies that are currently Read More…
Ataxia Treatment Pipeline Tracking progress of the development of Ataxia therapies. Treatment development is a long process that involves multiple phases of a clinical trial and oversight by the Food Read More…
Breaking Pharma News Informing the Ataxia community about drug development RECENT 2024 & OLDER ATAXIA RESEARCH OPPORTUNITIES Recent Ataxia Pharma News FDA Accepts Troriluzole Resubmission for Review October 22, 2026 Read More…
